Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) posted its earnings results on Tuesday. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10, Zacks reports. The firm had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance's quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.20 EPS.
Walgreens Boots Alliance Stock Up 0.8 %
Shares of WBA stock traded up $0.09 on Friday, hitting $10.78. The company's stock had a trading volume of 12,267,104 shares, compared to its average volume of 20,990,767. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market capitalization of $9.32 billion, a price-to-earnings ratio of -1.05, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The firm's fifty day moving average price is $10.75 and its 200-day moving average price is $10.07.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on WBA. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Friday. They issued a "hold" rating for the company. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $10.59.
Get Our Latest Stock Analysis on WBA
About Walgreens Boots Alliance
(
Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
